Gene expression in cell lines from human ameloblastoma immortalized using hTERT and HPV16-E6/E7

Oral Dis. 2022 Nov;28(8):2230-2238. doi: 10.1111/odi.13930. Epub 2021 Jun 21.

Abstract

Objective: The aim of this study was to evaluate and compare alterations in gene expression using two distinct immortalization methods (hTERT and HPV16-E6/E7) in ameloblastoma cell lines.

Materials and methods: A primary cell culture derived from human ameloblastoma (AME-1) was established and immortalized by two different methods using a transfection processes to hTERT and HPV-E6/E7. The RNA-seq was used to verify which immortalization method had less influence on gene expression. It was performed in four steps: extraction and collection of mRNA, PCR amplification, comparison with the human reference genome, and analysis of differential expression. The genes with differentiated expression were identified and mapped.

Results: RNA-seq revealed genetic alterations in ameloblastoma cell lines after the immortalization process, including increased expression of tumor genes like MYC, E2F1, BRAF, HRAS, and HTERT, and a decrease in tumor suppressor genes like P53, P21, and Rb.

Conclusions: It is possible to affirm that cell immortalization is not an inert method regarding gene regulation mechanisms and the hTERT method (AME-TERT) presented fewer changes in gene expression levels.

Keywords: RNA-Seq; ameloblastoma; cell immortalization; transcriptome.

MeSH terms

  • Ameloblastoma* / genetics
  • Cell Line
  • Cell Transformation, Viral / genetics
  • Gene Expression
  • Humans
  • Oncogene Proteins, Viral* / genetics
  • Oncogene Proteins, Viral* / metabolism
  • Papillomaviridae / genetics
  • Papillomavirus E7 Proteins / genetics
  • Proto-Oncogene Proteins B-raf / genetics
  • RNA, Messenger
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • Proto-Oncogene Proteins B-raf
  • RNA, Messenger
  • Tumor Suppressor Protein p53